Lorenz Oelschlager

Ratzeburger Allee 160
Luebeck, SH 23538, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Continuous Trimethoprim-Sulfamethoxazole Prophylaxis Does Not Affect Engraftment in Patients Undergoing Allogeneic Stem Cell Transplantation.

Continuous Trimethoprim-Sulfamethoxazole Prophylaxis Does Not Affect Engraftment in Patients Undergoing Allogeneic Stem Cell Transplantation.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: August 13, 2026

Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort.

Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort.

Journal: Leukemia & lymphoma

Published: July 28, 2026

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.

DECIDER-2: Prospective randomized multicenter phase III trial of decitabine and venetoclax administered in combination with all-trans retinoic acid or placebo in patients with acute myeloid leukemia who are ineligible for induction chemotherapy.

Journal: BMC cancer

Published: June 16, 2026

Discrepancies Between DRG-Based, Physician-Planned, and Actual Discharge Dates: A Retrospective Analysis of Oncological and Palliative Hospitalizations.

Discrepancies Between DRG-Based, Physician-Planned, and Actual Discharge Dates: A Retrospective Analysis of Oncological and Palliative Hospitalizations.

Journal: Deutsches Arzteblatt international

Published: April 20, 2026

Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards.

Precision Oncology in Northern Germany - Integrating Multi-Omics and AI to Support Evidence-Based Molecular Tumor Boards.

Journal: Oncology research and treatment

Published: February 04, 2026

FASTINA - protocol for a randomised feasibility trial of time-restricted eating to improve response to multiple myeloma therapy.

FASTINA - protocol for a randomised feasibility trial of time-restricted eating to improve response to multiple myeloma therapy.

Journal: Pilot and feasibility studies

Published: February 02, 2026

Survival in patients with monoclonal gammopathy of unknown significance after transcatheter aortic valve replacement: a global retrospective propensity-matched real-world analysis.

Survival in patients with monoclonal gammopathy of unknown significance after transcatheter aortic valve replacement: a global retrospective propensity-matched real-world analysis.

Journal: Cardio-oncology (London, England)

Published: November 24, 2025

Impact of Acute Myeloid Leukemia Cells on the Metabolic Function of Bone Marrow Mesenchymal Stem Cells.

Impact of Acute Myeloid Leukemia Cells on the Metabolic Function of Bone Marrow Mesenchymal Stem Cells.

Journal: International journal of molecular sciences

Published: April 11, 2025

Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases.

Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases.

Journal: Leukemia

Published: November 07, 2024

Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study.

Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study.

Journal: International journal of molecular sciences

Published: October 31, 2024

Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.

Comparison of five diagnostic flow cytometry scores in patients with myelodysplastic syndromes: Diagnostic power and prognostic impact.

Journal: Cytometry. Part B, Clinical cytometry

Published: June 24, 2021

Showing 1-11 of 11

Last Updated: 09/26/2026